These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1134 related items for PubMed ID: 16977652

  • 41. Quality of life in head and neck cancer patients after surgical resection: translation into Cantonese and validation of the EORTC QLQ-H&N35.
    Bower WF, Vlantis AC, Chung TM, Cheung SK, Bjordal K, van Hasselt CA.
    Acta Otolaryngol; 2009 Jul; 129(7):779-85. PubMed ID: 18767001
    [Abstract] [Full Text] [Related]

  • 42. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
    Chow E, Bottomley A.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
    [Abstract] [Full Text] [Related]

  • 43. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM, Borchgrevink PC, Saltnes T, Kaasa S.
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [Abstract] [Full Text] [Related]

  • 44. Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23.
    Chie WC, Chang KJ, Huang CS, Kuo WH.
    Psychooncology; 2003 Dec; 12(7):729-35. PubMed ID: 14502597
    [Abstract] [Full Text] [Related]

  • 45. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI, Arias F, Tejedor M, Pruja E, Marcos M, Martínez E, Valerdi J.
    Psychooncology; 2002 Dec; 11(3):249-56. PubMed ID: 12112486
    [Abstract] [Full Text] [Related]

  • 46. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.
    Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hiçsönmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioğlu U, Demiral AN, Hayran M.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1347-53. PubMed ID: 16169671
    [Abstract] [Full Text] [Related]

  • 47. The EORTC cancer outpatient satisfaction with care questionnaire in ambulatory radiotherapy: EORTC OUT-PATSAT35 RT. Validation study for Spanish patients.
    Arraras JI, Rico M, Vila M, Chicata V, Asin G, Martinez M, Hernandez B, Arias F, Martinez E.
    Psychooncology; 2010 Jun 01; 19(6):657-64. PubMed ID: 19771588
    [Abstract] [Full Text] [Related]

  • 48. [Utility of the questionnaire for quality of life EORTC-QLQ-C30 in psycho-oncological outcome research].
    Determann MM, Kollenbaum VE, Henne-Bruns D.
    Zentralbl Chir; 2004 Jan 01; 129(1):14-7. PubMed ID: 15011106
    [Abstract] [Full Text] [Related]

  • 49. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.
    Easson AM, Bezjak A, Ross S, Wright JG.
    Ann Surg Oncol; 2007 Aug 01; 14(8):2348-57. PubMed ID: 17505860
    [Abstract] [Full Text] [Related]

  • 50. Development of a European organization for research and treatment of cancer module to assess the quality of life of patients with proctitis after pelvic radiotherapy for malignancy.
    Spry N, Halkett G, Aoun S, Spry J, Yeoh E.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):522-8. PubMed ID: 18374505
    [Abstract] [Full Text] [Related]

  • 51. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
    Park J, Shin DW, Yun SJ, Park SW, Jeon SS, Kwak C, Kwon TG, Kim HJ, Ahn H.
    Oncology; 2013 Oct 01; 85(5):299-305. PubMed ID: 24217330
    [Abstract] [Full Text] [Related]

  • 52. Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands.
    Hoopman R, Muller MJ, Terwee CB, Aaronson NK.
    Eur J Cancer; 2006 Aug 01; 42(12):1839-47. PubMed ID: 16750911
    [Abstract] [Full Text] [Related]

  • 53. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III).
    Brandberg Y, Damato B, Kivelä T, Kock E, Seregard S, EORTC Ophthalmic Oncology Task Force, EORTC Quality of Life Group.
    Eye (Lond); 2004 Mar 01; 18(3):283-9. PubMed ID: 15004578
    [Abstract] [Full Text] [Related]

  • 54. An analysis of the psychometric properties of the translated versions of the European Organisation for the Research and Treatment of Cancer QLQ CX24 questionnaire in the two South African indigenous languages of Xhosa and Afrikaans.
    du Toit GC, Kidd M.
    Eur J Cancer Care (Engl); 2016 Sep 01; 25(5):832-8. PubMed ID: 26052872
    [Abstract] [Full Text] [Related]

  • 55. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T, Brandberg Y, Häggarth L, Hellström M, Nilsson S.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):51-9. PubMed ID: 15337539
    [Abstract] [Full Text] [Related]

  • 56. The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data.
    Morita S, Kaptein AA, Oba K, Sakamoto J.
    Psychooncology; 2008 May 01; 17(5):474-9. PubMed ID: 17847126
    [Abstract] [Full Text] [Related]

  • 57. Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.
    Caissie A, Nguyen J, Chen E, Zhang L, Sahgal A, Clemons M, Kerba M, Arnalot PF, Danjoux C, Tsao M, Barnes E, Holden L, Danielson B, Chow E.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1238-45. PubMed ID: 22172909
    [Abstract] [Full Text] [Related]

  • 58. Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
    Petersen MA, Groenvold M, Aaronson NK, Chie WC, Conroy T, Costantini A, Fayers P, Helbostad J, Holzner B, Kaasa S, Singer S, Velikova G, Young T, EORTC Quality of Life Group.
    Eur J Cancer; 2010 May 15; 46(8):1352-8. PubMed ID: 20231085
    [Abstract] [Full Text] [Related]

  • 59. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M, Kenne Sarenmalm E, Nasic S, Wengström Y, Gaston-Johansson F.
    J Pain Symptom Manage; 2013 Jul 15; 46(1):131-41. PubMed ID: 23195392
    [Abstract] [Full Text] [Related]

  • 60. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer.
    Vickery CW, Blazeby JM, Conroy T, Johnson CD, Alderson D.
    Br J Surg; 2000 Mar 15; 87(3):362-73. PubMed ID: 10718972
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.